Private company
ASLAN Pharmaceuticals Ltd
Last updated Oct 16, 2026.
Overview
-$44.2MNet income, fiscal 20232
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
-$46.6MFree cash flow2
Financial statements
No quarterly figures reported.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Gross profit | $2.6M4 | $12.0M2 | ||||||
| Operating income | -$8.7M5 | -$39.1M6 | -$42.3M7 | -$45.6M4 | -$16.5M8 | -$33.8M2 | -$47.9M2 | -$43.7M2 |
| Net income | -$9.0M5 | -$39.9M6 | -$42.2M7 | -$47.1M4 | -$17.0M8 | -$31.6M2 | -$51.4M2 | -$44.2M2 |
| Earnings per share | -$0.102 | -$0.152 | -$0.112 | |||||
| Earnings per share (diluted) | -$0.102 | -$0.152 | -$0.112 |
No quarterly figures reported.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Cash | $51.7M6 | $50.6M7 | $28.9M4 | $22.2M8 | $14.3M2 | $90.2M2 | $56.9M2 | $21.3M2 |
| Total assets | $51.3M5 | $52.9M6 | $23.3M7 | $16.1M4 | $94.5M8 | $61.2M2 | $24.6M2 | |
| Total liabilities | $15.8M5 | $22.3M6 | $24.0M7 | $26.2M4 | $37.2M8 | $52.8M2 | $37.9M2 | |
| Shareholders’ equity | $41.6M6 | $35.5M7 | $30.6M4 | -$603.3K8 | -$10.2M2 | $57.3M2 | $8.4M2 | -$13.3M2 |
| Shares outstanding | 160.2M shares5 | 190.0M shares6 | 237.7M shares7 | 402.1M shares4 | 402.1M shares8 |
Recent filings
- Jul 17, 20246-K
- Jul 15, 20246-K
- Jun 14, 20246-K
- May 31, 20246-K
- May 9, 20246-K
- May 7, 20246-K
- Apr 22, 20246-K
- Apr 19, 20246-K
- Apr 12, 20246-K
- Apr 12, 202420-F
- Apr 12, 20246-K
- Mar 13, 20246-K
- Mar 11, 20246-K
- Jan 24, 20246-K
- Jan 8, 20246-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8